Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

By Aude Bandini, Professeure agrégée, Philosophie (épistémologie et philosophie de la médecine), Université de Montréal
Jean-Philippe Drouin-Chartier, Professeur agrégé, Faculté de pharmacie, Université Laval
Pierre-Marie David, Professeur adjoint à la faculté de pharmacie, Université de Montréal
Rémi Rabasa-Lhoret, Professeur de médecine et de nutrition, Université de Montréal

We need to take stock of the promises and limitations of new “miracle” weight loss drugs such as Ozempic, Mounjaro and Wegovy.

Read complete article

~	Rescue of hiker missing for a fortnight welcome news down under

~	How we diagnose and define obesity is set to change – here’s why, and what it means for treatment

~	Protecting children, helping parents: NZ social workers speak about the challenges of their jobs

~	Why bad posh English accents still rule Hollywood, from Nosferatu to Gladiator II

~	Albanese says our laws would stop Elon Musk interfering in the Australian election. In truth, there’s little to stop him

~	Imposter participants challenge research integrity in the digital age

~	Can Trump deliver on his promise to end Russia’s invasion of Ukraine?

~	Trump’s plan for a strategic bitcoin reserve could trigger a crypto ‘arms race’ and reshape the global economic order

~	Staring blankly at your screen? You probably have post holiday blues. The good news is you can get through it

~	Study shows hot leaves can’t catch carbon from the air. It’s bad news for rainforests – and Earth